Q4 2022 GeoVax Labs Inc Earnings Call Transcript
Good afternoon, and welcome, everyone, to the GeoVax fourth quarter full year 2022 corporate update call. My name is Diego, and I will facilitate today's call. With me today are David Dodd, Chairman and CEO, Mark Reynolds, Chief Financial Officer, Mark Newman, Chief Scientific Officer, Dr. Kelly Mckee, Chief Medical Officer, and Dr. John Sharkey, Vice President Business Development. (Operator Instructions)
Please note this conference is being recorded. I will now turn the conference over to our host, Gabby DeGravina of CG Capital. Thank you. You may begin.
Thank you. Please note the following certain statements in this presentation may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from those included in these statements due to a variety of factors including whether GeoVax can develop and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
